Pomdoctor Ltd ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $57.2M0.0% YoYTTM through 31 Dec 2025
Net Income -$18.7MTTM through 31 Dec 2025
Free Cash Flow -$21.4MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 13.1% |
| EBITDA Margin | -29.6% |
| Operating Margin | -29.7% |
| Net Margin | -32.7% |
Returns
28.8%ROE
-94.7%ROA
Balance Sheet Health
Debt / Equity-1.31x
Current Ratio0.48x
Net Debt$63.6M
Cash & Equivalents$1.4M
Quality Metrics
Altman Z-Score-33.36
FCF Margin-37.4%
Multi-Year Trend
RevenueFY2025: $399.9M
Diluted EPS-$3.14TTMFY2025: $-3.14
Dividend
No dividend
Capital Allocation
R&D Spend$1.8M
Capex Intensity0.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Internet hospital | $21.6M | +69.3% | |
| Pharmaceutical supply chain | $35.6M |
Financials converted at 6.9961 from CNY.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.